A peptide that will not dissolve is usually not a defective peptide. It is a peptide being asked to go into the wrong solvent, or being asked too quickly. Solubility is a property of the sequence — its charge, its hydrophobicity, its tendency to stack against copies of itself — and the sequence is knowable before the vial is opened. Most failures are predictable from the amino acid composition alone.
Work out the charge first
The single most useful prediction comes from counting residues. Add up the basic ones (lysine, arginine, histidine) and the acidic ones (aspartate, glutamate), and take the difference, including the free termini.
| Net charge at pH 7 | Character | First solvent to try |
|---|---|---|
| Clearly positive | Basic | Water; if slow, dilute acetic acid |
| Clearly negative | Acidic | Water; if slow, dilute ammonium hydroxide |
| Near zero, hydrophilic | Neutral | Water, patiently |
| Near zero, hydrophobic | Difficult | Minimum organic co-solvent, then dilute |
The principle behind the whole table is that a charged molecule is solvated by water and an uncharged one is not. Move the pH away from the peptide's isoelectric point and it carries net charge and dissolves; sit at the isoelectric point and it is at its least soluble, by definition.
Why does a peptide dissolve at one pH and not another?
Because charge is what water has to work with. At its isoelectric point the positive and negative sites cancel, the molecule presents no net charge, and the electrostatic repulsion keeping copies apart disappears — so they aggregate instead of solvating. Shifting the pH in either direction restores a net charge, and both the solubility and the repulsion come back. A peptide that resists neutral water and goes readily into dilute acid has not changed; the solvent has stopped asking it to be neutral.
What counts as a hydrophobic sequence?
A useful rule of thumb is more than about half the residues drawn from the strongly hydrophobic set — valine, leucine, isoleucine, phenylalanine, tryptophan, methionine, alanine, proline — with little compensating charge. Such a sequence will not go into water at a useful concentration regardless of patience, and extended vortexing produces a suspension that pipettes inconsistently rather than a solution. The correct approach is the smallest workable volume of an organic solvent first, then dilution into aqueous buffer.
Aggregation is a different failure
Insolubility and aggregation look similar in a vial and are not the same problem. An insoluble peptide never entered solution. An aggregating peptide dissolved and then came back out, because copies associated with each other in preference to the solvent.
The usual driver is β-sheet formation: sequences with alternating hydrophobic residues stack into extended sheets, and once a nucleus exists it recruits more material. Three properties of aggregation make it worse than simple insolubility:
- It is concentration-dependent. A peptide fine at 0.1 mg/mL may aggregate at 5 mg/mL, so a concentrated stock can fail where a working dilution would not have.
- It is time-dependent. A solution that looks correct at reconstitution can develop haze over hours.
- It is often irreversible. Dilution does not reliably recover aggregated material; the sheets do not simply melt back.
How do I tell aggregation from ordinary insolubility?
By when it happened. Material that never dissolved leaves visible solid from the start, and the solution above it is clear. Aggregated material produces a solution that was clear and became hazy, opalescent, or gelled. The timing is the diagnostic. If a stock was clear yesterday and is cloudy today, the peptide dissolved and then came out — and making it more concentrated next time will make that worse rather than better.
Does an aggregated peptide still work?
Not reliably, and the more serious problem is that the concentration is no longer known. Aggregated material is out of solution, so the soluble fraction is lower than calculated by an unknown amount, and pipetting from a vial with suspended material delivers an inconsistent quantity. A result produced from an aggregated stock carries an error that is neither measured nor constant between replicates. Filtering removes the aggregate but not the uncertainty about how much peptide left with it.
Technique that prevents most of it
Add the solvent down the inner wall rather than directly onto the cake. Swirl; do not shake or vortex hard — foaming drives peptide to the air–liquid interface, which denatures it and seeds aggregation. Give it time: five or ten minutes of patience dissolves more material than thirty seconds of agitation. Equilibrate a cold vial to room temperature before opening, so atmospheric moisture does not condense into hygroscopic powder.
Where solubility is uncertain, test on a small portion rather than committing the vial. A few milligrams in a separate tube establishes whether the intended solvent works, and a failed test costs a fraction of the material instead of all of it.
Should I sonicate a peptide that will not dissolve?
Briefly and in a bath, if at all — never with a probe. Bath sonication in short bursts can help disperse a stubborn cake. Probe sonication delivers enough local energy to fragment peptide bonds and generates heat and cavitation at the tip, and for an aggregating sequence it supplies exactly the energy that nucleates more aggregate. If a peptide needs sonication to dissolve at all, the solvent is usually wrong, and changing the solvent is the better answer than applying more force.
What about peptides with cysteine?
Handle them under conditions that keep the thiols reduced, and expect solubility behaviour to change if they oxidise. Free cysteines form disulphide bridges with each other, and at concentration those bridges form between molecules as readily as within one — producing dimers and higher oligomers that behave like aggregate. Degassed buffer, slightly acidic pH, and minimal air exposure slow it. This is also why a free cysteine is the first thing that makes a peptide a poor candidate for co-formulation with another compound: the two can cross-link, and the mass barely moves, which makes it hard to detect.
Does a stock solution need re-checking before use?
Looking at it against the light takes two seconds and catches most of what goes wrong. Haze, a film, visible particulates, or a gel at the bottom all say the concentration on the label is no longer the concentration in the tube. The same goes for a vial that has been through repeated freeze–thaw, which concentrates solutes at the ice front and is one of the more reliable ways to nucleate aggregation — single-use aliquots remove that route entirely.
All products referenced here are supplied for laboratory and research use only. They are not drugs, foods, supplements or cosmetics, and are not for human or veterinary use.
